The recall affects only select 2 mg and 4 mg Semalix injection pens manufactured by Dr Reddy’s Laboratories, while all other semaglutide products remain unaffected.
The recall affects only select 2 mg and 4 mg Semalix injection pens manufactured by Dr Reddy’s Laboratories, while all other semaglutide products remain unaffected.